GlassScriptPhysician profile
Raheel Bengali
NPI 1376864512
$14,694.71
in general payments reported to CMS, 2019-2025
31 companies · $1,773 in 2025
The $1,773 reported for 2025 was more than what 75% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,780 · 2020: $1,285 · 2021: $1,872 · 2022: $2,790 · 2023: $1,444 · 2024: $2,750 · 2025: $1,773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,956 · Education: $11.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,955.50 |
| Education | $11.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,247.74 | 2019-2025 | Proclaim, Octrode, Ionicrf |
| Nevro Corp. | $2,922.33 | 2019-2024 | Senza |
| Medtronic, INC. | $1,569.34 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Synchromedii |
| Boston Scientific Corporation | $771.34 | 2019-2025 | Varithena Administration Pack, Intracept, General - Therapies |
| Relievant Medsystems, INC. | $595.79 | 2022-2023 | Intracept |
| Globus Medical, INC. | $548.15 | 2025 | Senza |
| Si-Bone, INC. | $327.05 | 2019-2025 | |
| Pfizer INC. | $284.04 | 2019-2021 | |
| Spr Therapeutics, INC | $205.15 | 2019-2025 | Sprint Pns System |
| Curonix LLC | $178.67 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spinal Simplicity, LLC | $143.10 | 2025 | Ha Minuteman G3-R |
| Medtronic USA, INC. | $141.78 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119.25 | 2020-2024 | Relistor |
| Stryker Corporation | $116.83 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $115.48 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $49.99 | 2024 | |
| Amgen INC. | $47.90 | 2019 | |
| Novartis Pharmaceuticals Corporation | $45.60 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $38.60 | 2021 | |
| Nalu Medical, INC. | $24.51 | 2023 | Nalu Neurostimulation System |
| Grt US Holding, INC. | $24.32 | 2019 | |
| Tonix Medicines, INC. | $22.77 | 2025 | Tonmya |
| Atland Pharmaceuticals, LLC | $21.14 | 2024 | Tolmetin Sodium, Orphenadrine Citrate, Aspirin and Caffeine |
| Tactile Systems Technology INC | $19.49 | 2025 | Flexitouch Plus, Nimbl |
| Bioventus LLC | $19.10 | 2025 | Gelsyn-3 |
| Vertex Pharmaceuticals Incorporated | $18.65 | 2025 | |
| Averitas Pharma INC. | $17.74 | 2025 | Qutenza |
| Mdd US Operations, LLC | $16.93 | 2019 | |
| Allergan, INC. | $16.01 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $13.21 | 2021 | |
| Horizon Therapeutics Plc | $12.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raheel Bengali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.